Using bacteria … treatment experiments that activate the immune system to eliminate cancer | Health | A must for better health | DW



[ad_1]

A new theory on which ongoing research in Switzerland in the fight and treatment of cancer diseases using bacteria as a means to eliminate the cancerous tumors in the human body. Bacteria are known to be classified as factors that cause fatal disease, along with other factors such as DNA damage, genomic instability, etc.

Chlamydia bacteria, for example, are seen by doctors as a real, high-risk risk of uterine, as well as prostate and colon cancer, as doctors suggest that gut bacteria have a part in them.

A Swiss startup named (T3 Pharma) is behind this new bet, which is not based on the belief of “his cure for what the disease was”, but rather challenges the roof to convert bacteria into a treatment which replaces the traditional treatments used, represented in the chemical and radiation sessions responsible for the damage. A dangerous aspect that the patient has no choice but to endure.

The beginning of clinical trials

The tests conducted so far were dependent on a bacterium called “Yersinia coli”. It is a Gram-negative bacterium and causes many diseases of varying severity, including those that do not show any symptoms and others that can cause death, especially in young children. In Germany, for example, the bacterium “Yersinia coli” was placed in the third class on the list of dangerous bacteria that cause gastrointestinal diseases according to the classification of the Bavarian State Health Office.

According to the site “Badrunner Platt”, the company in question will begin its clinical trials early next year after obtaining a loan of around 23 million euros from some investors, in light of the growing concern about the fate of cancer patients, as they are among the most affected by the spread of the new Corona virus epidemic.

Submission to the immune response

In prospective clinical trials, cancer patients will be injected with live bacteria which will be tasked with carrying proteins to cancer cells to destroy them and rebuild healthy tissue within them, in a process known to experts as “the third type of secretion system in bacterial cells “.

Through this method, the modified bacteria will do their traditional job, but in the opposite direction: as a sensory vector in search of the presence of eukaryotes, the modified bacteria will usually look for these carcinogens and secrete proteins into them, producing a series of effects that help destroy the pathogen and fall into the grip of the immune response.

This method would be more effective than all the methods of treatment adopted so far, because it damages the cancer cells from within and depends primarily on the body’s immune system. The Swiss company clarifies that the goal is to “activate the immune system” to take on the task of eliminating cancer.

و.ب / ص.ش

.

[ad_2]
Source link